Roberto Scarpioni
Advanced in Atheroembolic Renal Disease

Roberto Scarpioni

Piacenza, IT 
Advanced in Atheroembolic Renal Disease
Piacenza, IT 
OverviewLocationsClinical Research

Overview

Roberto Scarpioni practices in Piacenza, Italy. Mr. Scarpioni is rated as an Advanced expert by MediFind in the treatment of Atheroembolic Renal Disease. His top areas of expertise are Atheroembolic Renal Disease, Familial Cold Autoinflammatory Syndrome, Neonatal Onset Multisystem Inflammatory Disease, and Muckle-Wells Syndrome.

His clinical research consists of co-authoring 25 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Atheroembolic Renal Disease.

Gender
Male

Locations

Piacenza, Italy
Other Locations
Teramo, Italy
Cagliari, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
Non-Interventional, Exploratory, Phase IV, Single-Blind, Cross-Sectional, Randomised, Cross-over Study Evaluating Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease & Hyperkalaemia (APPETIZE).
Non-Interventional, Exploratory, Phase IV, Single-Blind, Cross-Sectional, Randomised, Cross-over Study Evaluating Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease & Hyperkalaemia (APPETIZE).
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
View 1 Less Clinical Trial

25 Total Publications

Il progetto PIRP: un'intuizione di vent'anni fa, oggi più che mai attuale
Il progetto PIRP: un'intuizione di vent'anni fa, oggi più che mai attuale
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
Published: November 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Scarpioni's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile